The U.S. Senate removed a proposed $400 million funding cut to the country’s flagship HIV/AIDS program, PEPFAR, from President Donald Trump’s multibillion-dollar rescissions package.
The rescission package aims to claw back funds previously approved by Congress.
Sparing this funding is a move that’s being celebrated by the global health community — but it comes in the wake of the Trump administration’s broader battering of HIV programming in the past six months due to a barrage of steps taken to dismantle America’s foreign aid apparatus.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
